JKS logo
  Jouhou Koukai Services LLC

READING ROOM



formatting


Regulatory & Commercial News >>

2009 >>


March 31, 2009: JKS News: The Committee of Drugs of PAFSC, MHLW MHLW Headoffice in TokyoMHLW Headoffice in Tokyo pre-approved Clozapine of Novartis Pharma KK Novartis Pharma KK headoffice in TokyoNovartis Pharma KK headoffice in Tokyo, 13 other products ... Details in JAD Databases
March 30, 2009: JKS News: Chugai Seiyaku KK Chugai Seiyaku headoffice in Mitsui Honkan BldgChugai Seiyaku headoffice in Mitsui Honkan Bldg has achieved largest share (15.8%) in Japan anticancer market ... Roche/Chugai products in JAD Databases | related readings
March 27, 2009: PMDA: Pharmaceuticals and Medical Devices Safety Information Bulletin No. 256 PMDISPMDSI released, Atarax (Hydroxyzine pamoate) adverse events summarized ... Pfizer products in JAD Databases | Epidemiology of allergy consulting
March 26, 2009: JKS News: Two group companies of Mitsubishi Chemical Holdings KK - the Tanabe-Mitsubishi Seiyaku KK Tanabe-Mitsubishi logoTanabe-Mitsubishi logo manufacturer of Medway Injections (human serum albumin genetical recombination), and the sales promoter Benesis KK Benesis logoBenesis logo started a product recall and requested revocation of the approval due to questionable pre-clinical data and validation issues ... TM product details in JAD Databases
March 26, 2009: JKS News: The Medical Treatment Fee Basic Problems Subcommittee to the Central Social Insurance Medical Council (CSIMC) CSIMC meeting (archival photo)CSIMC meeting (archival photo) published an overview report detailing the actual increased use of generics in FY 2008 ... Generics report preview
March 25, 2009: JKS News: The Japan Health Sciences Foundation (JHSF) JHSF Headoffice in TokyoJHSF Headoffice in Tokyo completed the 2008 update of the "Research and Development Strategy in the Era of Global Development: New Approaches in Drug Discovery and Pipeline Creation" report comparing 19 EU and US major pharmas, top ranking Novartis Novartis Pharma KK headoffice in TokyoNovartis Pharma KK headoffice in Tokyo ... Novartis pipeline in JAD Database
March 24, 2009: PMDA PMDA Headoffice in TokyoPMDA Headoffice in Tokyo announced improvement of the NDA review procedures, CTD handling, PMDA consultations from April 1 ... eCTD & dossier support services
March 23, 2009: JKS News: The four group companies of Bristol-Myers Squibb Company (BMS) Bristol-Myers Squibb Company logoBristol-Myers Squibb Company logo in Japan: Bristol Seiyaku YK (BPYK), Bristol-Myers KK (BMKK), Bristol-Myers Squibb YK (BMSYK) and Mead Johnson KK (MJKK) to embark on major expansion of the sales force to reach 760 medical representatives within 3 years for a range of new drugs ... BMS products in JAD Databases
March 22, 2009: Daiichi-Sankyo KK Daiichi-Sankyo HQ, TokyoDaiichi-Sankyo HQ, Tokyo filled for patent infringement of Cravit (Levofloxacin hydrate) against 13 generics makers: Shiono Chemical KK, Taiyo Yakuhin KK, Takata Seiyaku KK, Nichi-Iko Seiyaku KK, Nihon Generic KK, Mylan Seiyaku KK, and Yoshindo KK, Ohara Seiyaku KK, Sawai Yakuhin KK, Taisho Seiyaku KK, Choseido Seiyaku KK, Towa Yakuhin KK and Nipro Pharma KK ... Daiichi-Sankyo products in JAD Databases
March 20, 2009: JKS News: MHLW MHLW Headoffice in TokyoMHLW Headoffice in Tokyo extrapolates 37,800 nation-wide juvenile dementia (under 65 y.o.) patients ... Epidemiology consulting
March 19, 2009: JKS News: MHLW MHLW Headoffice in TokyoMHLW Headoffice in Tokyo decided to re-start with a newly developed product the routine vaccinations against Japanese encephalitis discontinued in 2006 after a series of acute disseminated encephalomyelitis cases ... Vaccines in JAD Databases | Relevant report
March 18, 2009: The World Intellectual Property Organization (WIPO) WIPO logoWIPO logo reported a record number of cybersquatting cases in 2008, as biotechnology and pharmaceutical corporate and product domains are most frequently (10%) infringed ... Pharma IP consulting
March 17, 2009: JKS News: Pharmaceuticals and Food Safety Bureau (PFSB) of MHLW MHLW Headoffice in TokyoMHLW Headoffice in Tokyo revises the key notification on "Specifications on the Range of Drugs" to include provisions for bio-similars (bio follow-on drugs) ...
March 16, 2009: Nihon Keizai Shimbun: In the annual closing of the fiscal year ranking on liquidity the pharma companies Dainippon Sumitomo Seiyaku KK Dainippon Sumitomo Seiyaku KK logoDainippon Sumitomo Seiyaku KK logo and specialty drug developer Seikagaku KK Seikagaku KK headoffice in TokyoSeikagaku KK headoffice in Tokyo took 9th and 23rd places among the TSE listed Japanese companies with market cap over 50 billion Yen Dainippon Sumitomo products in JAD Databases
March 13, 2009: JKS News: Gilead Sciences Gilead Sciences logoGilead Sciences logo outbid the hostile offer for CV Therapeutics; Astellas Seiyaku KK Astellas Seiyaku KK headquarters in Nihonbashi, TokyoAstellas Seiyaku KK headquarters in Nihonbashi, Tokyo - 6% stock owner and plaintiff against CVT still has the option to increase the offer... Gilead products in JAD Databases
March 12, 2009: The World Kidney Day World Kidney Day logoWorld Kidney Day logo to be observed in Japan today... Kidney disease market in Japan
March 11, 2009: JKS News: After the approval of Cinacalcet for secondary hyperparathyroidism Kyowa Hakko Kirin KK Kyowa Hakko Kirin KK logoKyowa Hakko Kirin KK logo submits for extended indications of renal anemia drug for treatment of pre-dialysis patients aiming to increase its overall share in the kidney failure market ... Kyowa Hakko Kirin products in JAD Databases
March 10, 2009: JKS News: Astellas Seiyaku KK Astellas Seiyaku KK headquarters in Nihonbashi, TokyoAstellas Seiyaku KK headquarters in Nihonbashi, Tokyo plans to dispose the entire board of CV Therapeutics CV Therapeutics corporate office in Palo Alto, CACV Therapeutics corporate office in Palo Alto, CA including the Founder and perennial Chairman cum CEO Dr. Louis G. Lange CVT Louis G. LangeCVT Louis G. Lange ... Astellas products in JAD Databases
March 9, 2009: Merck to reverse-merger with Schering-Plough, expects regulatory approvals in Japan from where projects 6% share (3 billion US$) of the combined global sales ... Banyu (Merck) and Schering-Plough products in JAD Databases
March 6, 2009: Shionogi Seiyaku KK Shionogi Seiyaku headoffice in OsakaShionogi Seiyaku headoffice in Osaka launched a public awareness campaign on Chronic Kidney Disease (CKD) ... Epidemiology of CKD
March 4, 2009: JKS News: If approved the re-introduced "Pharmaceutical Market Access and Drug Safety Act would provide for importation of FDA-endorsed medications from Japan ... Pricing and Reimbursement (P&R) consulting
March 3, 2009: PMDA PMDA Headoffice in TokyoPMDA Headoffice in Tokyo starts to accept applications for consultations in April for bioventures in the fields of regenerative medicine, preventive vaccines, gene therapy and innovative medical devices ... Consulting services
March 2, 2009: JKS News: MHLW MHLW Headoffice in TokyoMHLW Headoffice in Tokyo approved dry cell culture vaccine for Japanese encephalitis developed by BIKEN (Osaka University Research Institute for Microbial Diseases) Biken main facility in OsakaBiken main facility in Osaka ... Unapproved therapies report preview
February 28, 2009: JKS News: Astellas Seiyaku KK Astellas Seiyaku KK headquarters in Nihonbashi, TokyoAstellas Seiyaku KK headquarters in Nihonbashi, Tokyo launched yet another hostile bid for all shares of CV Therapeutics CV Therapeutics corporate office in Palo Alto, CACV Therapeutics corporate office in Palo Alto, CA ... Astellas products in JAD Databases | Unapproved prospective products preview
February 27, 2009: JKS News: Eisai KK Eisai KK logoEisai KK logo to re-organize its 2,000-strong R&D force into 13 units across international borders under a new E-Pharma" management model; all researchers from the acquired MGI Pharma MGI Pharma headofficeMGI Pharma headoffice to join the oncology unit ... Previous coverage  |  Related readings
February 26, 2009: Schering-Plough KK Schering-Plough KK Tokyo headquarters building office in ShinjukuSchering-Plough KK Tokyo headquarters building office in Shinjuku re-launched a Hepatitis C dedicated web site (C-KAN NET) targeting both patients and physicians ... Schering-Plough products in JAD Databases | Interferon consulting
February 23, 2009: The annual survey of Nihon Keizai Shimbun Nihon Keizai Shimbun HQNihon Keizai Shimbun HQ ranks Eisai KK Eisai KK logoEisai KK logo as No. 1 and the most defensive stock in terms of steady return of dividends; five out of the 10 top stops occupied by pharmas ... Eisai products in JAD Databases
February 20, 2009: JKS News: The European subsidiary of Eisai KK Eisai brandEisai brand obtained EU marketing rights for still unapproved anti-epileptic drug Zebinix (eslicarbazepine acetate) from Bial-Portela & Ca. SA Bial-Portela & Ca. SA logoBial-Portela & Ca. SA logo against 11 billion Yen ... previous Eisai acquisition news coverage
February 17, 2009: PMDA PMDA Headoffice in TokyoPMDA Headoffice in Tokyo held the "PMDA Third International Symposium on Biologics", with keynote speech on "Current status of Japanese Regulation and Development on Biologics" ... related resources
February 16, 2009: JKS News: Teva KK TAPI International logoTAPI International logo - a subsidiary of Teva Pharmaceutical Industries Ltd. and the unlisted Kowa KK Kowa KK summary of activitiesKowa KK summary of activities - announced a plan through their JV Teva-Kowa Pharma KK to introduce about 300 generic products by 2015. All major Japanese generics makers are expected to report higher profit for FY 2008 ... Teva Master Files and Kowa products in JAD Databases | Generics report preview
February 12, 2009: JKS News: The Economic Affairs Division, Health Policy Bureau, MHLW MHLW Headoffice in TokyoMHLW Headoffice in Tokyo announced that as a result of "Public-Private Dialogue for Drug Discovery and Innovation" initiative will be set forth to focus on regenerative medicine, including private cell culture banks and to clarify the legal status ... Unapproved therapies report preview
February 6, 2009: JKS News: The major vaccine producer Kaketsuken Foundation The Chemo-Sero-Therapeutic Research Institute headoffice in TokyoThe Chemo-Sero-Therapeutic Research Institute headoffice in Tokyo tied up with for GlaxoSmithKline Japan KK GSK headoffice in TokyoGSK headoffice in Tokyo and GSK Biologicals to develop pandemic anti-flu vaccine ... Vaccines in JAD Databases | Vaccine report preview
February 5, 2009: JKS News: Astellas Seiyaku KK Astellas Seiyaku KK headquarters in Nihonbashi, TokyoAstellas Seiyaku KK headquarters in Nihonbashi, Tokyo announced organizational changes in global development; reshuffling of top corporate management, financial, legal and strategy executives to be implemented effective April 1 ... Astellas products in JAD Databases
February 3, 2009: JKS News: The Office of Pharmaceutical Industry Research (OPIR) to the Japan Pharmaceutical Manufacturers Association (JPMA) JPMA Office bldg in TokyoJPMA Office bldg in Tokyo released the Research Paper No. 44 "Survey of Pharmaceutical Companies about the Economic Evaluation of Drugs" ... JAD consulting services  |  Pricing & Reimbursement report preview
February 2, 2009: The The FDA staff quoted (Reuters) the agency would conditionally approve Prasugrel discovered by Ube Kousan KK Ube Kousan HQ, TokyoUbe Kousan  HQ, Tokyo , developed by Daiichi-Sankyo KK Daiichi-Sankyo HQ, TokyoDaiichi-Sankyo HQ, Tokyo and scheduled for co-marketing with Eli Lilly Eli Lilly logoEli Lilly logo as Effient ... Ube Kousan, Nippon Eli Lilly and Daiichi-Sankyo products in JAD Databases
January 29-30, 2009: JKS News: The First and Second Subcommittees of Drugs of PAFSC, MHLW MHLW Headoffice in TokyoMHLW Headoffice in Tokyo recommended for approval anti AHDH drug; positively review orphan drug ... Orphan drugs (ODD) in JAD Databases | Report preview
January 29, 2009: JKS News: After a decade of peaceful collaboration Astellas Seiyaku KK Astellas Seiyaku KK headquarters in Nihonbashi, TokyoAstellas Seiyaku KK headquarters in Nihonbashi, Tokyo made public its second hostile bid for all shares of CV Therapeutics CV Therapeutics corporate office in Palo Alto, CACV Therapeutics corporate office in Palo Alto, CA ; the CVT board responds with 1-year extension of anti-takeover measures ... Astellas products in JAD Databases | Unapproved prospective products preview
January 27, 2009: JKS News: The fourth-ranked Pfizer KK launched 55th Anniversary PR campaign Pfizer Japan tv commercialPfizer Japan tv commercial prepares for integration of 1,000-strong Wyeth KK Wyeth Japan headoffice building in TokyoWyeth Japan headoffice building in Tokyo ... previous Pfizer news | Pfizer and Wyeth products in JAD Databases
January 26, 2009: JKS News: Daiwa Shoken SMBC KK Daiwa Securities office building in TokyoDaiwa Securities office building in Tokyo , a leading equity house to start offering in Japan the issued by the International Finance Facility for Immunisation Company (IFFIm) IFFIm logoIFFIm logo and the GAVI Alliance Global Alliance for Vaccines and Immunization logoGlobal Alliance for Vaccines and Immunization logo "vaccine bonds" ...  Vaccine report preview
January 21, 2009: The Minister of MHLW MHLW Headoffice in TokyoMHLW Headoffice in Tokyo approved 18 new products and formulations, Novartis Pharma KK Novartis Pharma KK headoffice in TokyoNovartis Pharma KK headoffice in Tokyo has a record 4 new approvals ... full details in JAD Database
January 20, 2009: JKS News: Ten years after Nippon Roche KK Nippon Roche KK headoffice in TokyoNippon Roche KK headoffice in Tokyo failure with Orlistat registration Taisho Seiyaku KK Taisho Seiyaku KK headofficeTaisho Seiyaku KK headoffice obtained a license from Glaxo Group Ltd (UK) for OTC development in Japan thus targeting the multimillion obese population ... Disease epidemiology consulting and data
January 19, 2009: JKS News: In a rare litigation case Teijin Pharma KK Teijin Pharma KK headoffice bldg. in Kasumigaseki, TokyoTeijin Pharma KK headoffice bldg. in Kasumigaseki, Tokyo is suing a smaller generic rival Towa Yakuhin KK Towa Yakuhin KK HQ in OsakaTowa Yakuhin KK HQ in Osaka over package imitation Packages of Rhinocort Nasal Spray (Teijin, left) and Beclometasone Nasal Spray (Towa, right)Packages of Rhinocort Nasal Spray (Teijin, left) and Beclometasone Nasal Spray (Towa, right) of Beclometasone dipropionate decongestant nasal spray... Teijin and Towa products in JAD Databases | Competitive consulting
January 15, 2009: JKS News: Unmet Medical Needs Pharma KK (UMN Pharma) UMN Pharma logoUMN Pharma logo announced that the in-licensed in 2006 from Protein Sciences Corp. Protein Sciences Corporation offices, research laboratories and cGMP production facilities located in Meriden, Connecticut, USAProtein Sciences Corporation offices, research laboratories and cGMP production facilities located in Meriden, Connecticut, USA FluBlok anti-H5N1 recombinant influenza vaccine was successful in the 125-subjects Japan Phase I trial ... product details in JAD Databases | Vaccine report preview | related readings
January 14, 2009: JKS News: MHLW MHLW Headoffice in TokyoMHLW Headoffice in Tokyo 2007 "National Health and Nutrition Examination Survey" found 29% of population at risk of diabetes, over 40s particularly affected ... Epidemiology consulting and data
January 13, 2009: JKS News: Dr. Taro Tsukahara, a graduate of Jichi Medical University Jichi Medical UniversityJichi Medical University assumed the position of MHLW Secretariat Counselor in charge of pharmaceuticals and food ... related laws
January 9, 2009: Wholesalers dynamics: Due to competitive reasons the largest drug wholesaler Mediceo Paltac Holdings KK Mediceo Paltac Holdings KK logoMediceo Paltac Holdings KK logo and No. 2 Alfresa Holdings KK Alfresa Holdings Headoffice in TokyoAlfresa Holdings Headoffice in Tokyo scrapped the planned 4 trillion Yen merger; the fourth-largest wholesaler Toho Yakuhin KK Toho Yakuhin Headoffice in TokyoToho Yakuhin Headoffice in Tokyo to acquire mid-size Hiroshima-based Omwell KK Omwell KK logoOmwell KK logo ... Consulting services | Pricing & Reimbursement in Japan report preview
January 6, 2009: JKS News: Daiichi-Sankyo KK Daiichi-Sankyo brandmarkDaiichi-Sankyo brandmark announced a non-cash valuation loss of 359.5 billion Yen on its shares and one-time write-down of goodwill on its investment in Ranbaxy Laboratories Ltd (RLL) Ranbaxy Laboratories LimitedRanbaxy Laboratories Limited reflecting the more than 50% decline in the market value of RLL securities versus the purchase price with anticipated significant negative impact on net income, but not on shareholders dividends for the FY 2008 ... Daiichi Sankyo products in JAD Databases
January 5, 2009: JKS News: In 2009 the Japanese pharmaceutical industries unscathed by the global financial crisis reorienting toward BRIC (Brazil, Russia, India and China) countries and other emerging markets ... Key reading


News archive (2012-2006)>>

 

Archived headline news from other periods could be found here:


Notice >>

 

The JAD News Database is currently in beta-testing and expected to be launched in 2011 for all registered users


Registered users of JAD Databases>>


JAD users login button


Copyright © 2001-2013 and Database Rights owned by Jouhou Koukai Services LLC. All rights reserved worldwide.
All materials on this web site are protected by copyrights. Jouhou Koukai and Jouhou Koukai logo are service marks of JKS LLC.

Terms & Conditions | Inquiries to Regulatory Department